Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 585065생성일: 2026년 10월 25일
Diisopropylethylamine → 3-(4-{[3-(3-Fluorophenyl)(1,2,4-oxadiazol-5-yl)]methyl}piperazinyl)-1-(2-methylbenzothiazol-5-yloxy)propan-2-ol
https://huagongshe.com/reaction/585065
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | 5-(Chloromethyl)-3-(3-fluorophenyl)-1,2,4-oxadiazole | HCID 16736248 | — |
| 반응물 | 1-(2-Methylbenzothiazol-5-yloxy)-3-piperazin-1-ylpropan-2-ol | HCID 21911691 | — |
| 용매 | Ethanol | HCID 702 | — |
| 생성물 | 3-(4-{[3-(3-Fluorophenyl)(1,2,4-oxadiazol-5-yl)]methyl}piperazinyl)-1-(2-methylbenzothiazol-5-yloxy)propan-2-ol | HCID 22064207 | — |
반응 단계
To 5-(chloromethyl)-3-(3-fluorophenyl)-1,2,4-oxadiazole (300 mg, 1.41 mmol) and 1-(2-methylbenzothiazol-5-yloxy)-3-piperazine-1-yl-propan-2-ol, a compound of formula (6) (291 mg, 0.94 mmol) in EtOH (20 mL, anhydrous) was added diisopropylethylamine (0.329 m, 1.89 mmol), and the reaction was shaken on a J-Kem™ block overnight at 90° C. Upon cooling to room temperature, the solution was concentrated to an oil and purified on an Isco™ Combi Flash Si 10X, using Redi Sep columns (10 g), eluting with ethyl acetate, then gradient to 4:1 ethyl acetate/methanol, to yield 3-(4-{[3-(3-fluorophenyl)(1,2,4-oxadiazol-5-yl)]methyl}piperazinyl)-1-(2-methylbenzothiazol-5-yloxy)propan-2-ol, a compound of Formula I, (136 mg, 30%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06930111B2 |
|---|
| 출처 데이터셋 | uspto-grants-2005_08 |
|---|
| ORD ID | ord-107f667267564e1cad1bdc3f4907e1ef |
|---|
| 출처 메모 | uspto-grants-2005_08 |
|---|